Cargando…

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease

In the last decades, the global prevalence of non-alcoholic fatty liver disease (NAFLD) has reached pandemic proportions with derived major health and socioeconomic consequences; this tendency is expected to be further aggravated in the coming years. Obesity, insulin resistance/type 2 diabetes melli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Montoro, José Ignacio, Cornejo-Pareja, Isabel, Gómez-Pérez, Ana María, Tinahones, Francisco J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625016/ https://www.ncbi.nlm.nih.gov/pubmed/34836332 http://dx.doi.org/10.3390/nu13114077

Ejemplares similares

Obesity‐related glomerulopathy: Current approaches and future perspectives
por: Martínez‐Montoro, José Ignacio, et al.
Publicado: (2022)

Heart Failure in Type 1 Diabetes: A Complication of Concern? A Narrative Review
por: Gómez-Perez, Ana María, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
por: Juanola, Oriol, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Factors Related to Weight Loss Maintenance in the Medium–Long Term after Bariatric Surgery: A Review
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2021)

Genetic Polymorphisms in Non-alcoholic Fatty Liver Disease in Obese Egyptian Children
por: El-Koofy, Nehal M., et al.
Publicado: (2011)

Does Metabolically Healthy Obesity Exist?
por: Muñoz-Garach, Araceli, et al.
Publicado: (2016)

Metabolic and Endocrine Consequences of Bariatric Surgery
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2019)

Differential Microbial Pattern Description in Subjects with Autoimmune-Based Thyroid Diseases: A Pilot Study
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2020)

Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
por: Torres, Jorge-Luis, et al.
Publicado: (2018)

“Triple-negative” non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2022)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
por: Martin-Nuñez, Gracia M., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
por: Wajsbrot, Natalia Balassiano, et al.
Publicado: (2022)

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
por: Iwaki, Michihiro, et al.
Publicado: (2023)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
por: Gallego-Durán, Rocío, et al.
Publicado: (2022)

Malignant mixed Müllerian tumour of the uterus associated with non-islet cell tumour hypoglycaemia
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2021)

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
por: Papandreou, Christopher, et al.
Publicado: (2017)

Helicobacter pylori Eradication Therapy Affect the Gut Microbiota and Ghrelin Levels
por: Martín-Núñez, Gracia Mª, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese
por: Kawaguchi, Takahisa, et al.
Publicado: (2012)

Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non‐alcoholic fatty liver disease
por: Gibson, P. S., et al.
Publicado: (2018)

Non-alcoholic fatty liver disease: a narrative review of genetics
por: Danford, Christopher J., et al.
Publicado: (2018)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
por: Martin, Katherine, et al.
Publicado: (2021)

Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2020)

Role of Leptin in Non-Alcoholic Fatty Liver Disease
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
por: Martínez–Sánchez, Celia, et al.
Publicado: (2023)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat
por: Quintás, Guillermo, et al.
Publicado: (2022)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease
por: Kapil, Shweta, et al.
Publicado: (2016)

Predictors of Sarcopenia in Outpatients with Post-Critical SARS-CoV2 Disease. Nutritional Ultrasound of Rectus Femoris Muscle, a Potential Tool
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ih26mbpbph3u9gs55hdmbmperg